PET/computed tomography and lymphoma
- PMID: 24010908
- DOI: 10.1016/j.rcl.2013.05.004
PET/computed tomography and lymphoma
Abstract
[¹⁸F]Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scans provide patients and referring physicians with diagnostic PET and CT information in a single imaging session. Because most lymphomas show high glucose metabolic activity and FDG avidity, they can be reliably assessed with FDG-PET/CT. PET/CT has emerged as the modality of choice for treatment strategy assessments in patients with lymphoma. Its ability to characterize masses as benign or malignant and its high sensitivity and specificity for staging, restaging, and treatment monitoring have led to widespread acceptance of PET imaging for managing patients with lymphoma.
Keywords: FDG; Lymphoma; PET; PET/CT.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.Radiol Clin North Am. 2008 Mar;46(2):199-211, vii. doi: 10.1016/j.rcl.2008.03.004. Radiol Clin North Am. 2008. PMID: 18619376 Review.
-
¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.Nucl Med Commun. 2012 Mar;33(3):313-21. doi: 10.1097/MNM.0b013e32834ee824. Nucl Med Commun. 2012. PMID: 22237387
-
The role of FDG-PET imaging in the management of lymphoma.Clin Adv Hematol Oncol. 2004 Feb;2(2):115-21. Clin Adv Hematol Oncol. 2004. PMID: 16163171 Review.
-
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.Ann Nucl Med. 2008 Nov;22(9):795-802. doi: 10.1007/s12149-008-0186-4. Epub 2008 Nov 28. Ann Nucl Med. 2008. PMID: 19039558
-
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.PET Clin. 2015 Jul;10(3):423-30. doi: 10.1016/j.cpet.2015.03.011. PET Clin. 2015. PMID: 26099676 Review.
Cited by
-
(18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.Asia Ocean J Nucl Med Biol. 2014 Spring;2(1):57-64. Asia Ocean J Nucl Med Biol. 2014. PMID: 27408859 Free PMC article.
-
Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group.Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):245-249. doi: 10.1016/j.htct.2018.03.002. Epub 2018 Apr 24. Hematol Transfus Cell Ther. 2018. PMID: 30128433 Free PMC article.
-
Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.BMC Cancer. 2015 May 8;15:378. doi: 10.1186/s12885-015-1381-z. BMC Cancer. 2015. PMID: 25953144 Free PMC article.
-
Multimodal imaging diagnosis of pancreatic Castleman disease with abdominal and retroperitoneal lymphadenopathy: a case report and literature review.Front Oncol. 2024 Nov 27;14:1502878. doi: 10.3389/fonc.2024.1502878. eCollection 2024. Front Oncol. 2024. PMID: 39664189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
